Total amount raised
$48.9 Millions
Latest funding date
08/01/2024
Location
SigTuple has successfully raised $4 million in an extended Series C round led by SIDBI Venture. The company builds intelligent solutions for medical diagnosis using state-of-the-art machine learning techniques.
Keep reading to explore the intricacies of SigTuple's fundraising journey and the investors backing this innovative platform.
What Is SigTuple?
SigTuple, founded on July 24, 2015, in Bangalore, Karnataka, India, builds intelligent solutions for medical diagnosis using state-of-the-art machine learning techniques. The company aims to revolutionize the global medical diagnostic space through data-driven intelligence.
SigTuple was founded by Apurv Anand, Bharath Cheluvaraju, Rohit Kumar Pandey, and Tathagato Dastidar. The company focuses on creating a data-driven, machine-learned, cloud-based solution for detecting anomalies and trends in medical data, improving the accuracy and efficiency of disease diagnosis.
Currently, SigTuple employs between 101-250 people, working towards enhancing the accuracy and efficiency of disease diagnosis through innovative technology.
How Much Funding Has SigTuple Raised?
- Series C
- Amount Raised: $4 million
- Date: August 2024
- Lead Investors: SIDBI Venture Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funds will be used for geographical expansion, broadening the product portfolio, and supporting regulatory clearances.
- Series C
- Amount Raised: $4.3 million
- Date: March 2023
- Lead Investors: Accel, Endiya Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funds will be used to drive geographical expansion, expand the product portfolio, and support regulatory clearances.
- Series C
- Amount Raised: $16 million
- Date: April 2019
- Lead Investors: Trifecta Capital Advisors
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funds were likely aimed at advancing AI-driven medical diagnostic solutions and expanding market presence.
- Venture Round
- Amount Raised: Not publicly disclosed
- Date: January 2019
- Lead Investors: iLabs Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funds were likely used to support product development and market expansion.
- Series B
- Amount Raised: $19 million
- Date: June 2018
- Lead Investors: Accel, Chiratae Ventures, IDG Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funds were likely used to enhance product offerings and expand market reach.
- Debt Financing
- Amount Raised: Not publicly disclosed
- Date: June 2018
- Lead Investors: Trifecta Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funds were likely used to support operational expenses and product development.
- Grant
- Amount Raised: $15,000
- Date: February 2018
- Lead Investors: NetApp Excellerator
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funds were likely used to support early-stage product development and innovation.
- Series A
- Amount Raised: $5.8 million
- Date: February 2017
- Lead Investors: Accel
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funds were likely used to scale operations and enhance product development.
- Seed Round
- Amount Raised: Not publicly disclosed
- Date: February 2016
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funds were likely used to kickstart the company's operations and initial product development.
SigTuple has raised a total of $49.115 million to date. The current valuation is not publicly disclosed.
Key Investors
- SIDBI Venture Capital
- Details: SIDBI Venture Capital is a venture capital firm that led the extended Series C funding round for SigTuple. The firm focuses on supporting startups and SMEs in various sectors, including healthcare.
- Investment Focus Areas: Startups, SMEs, healthcare
- Notable Investments: Not publicly disclosed
- Endiya Partners
- Details: Endiya Partners is a venture capital firm that participated in both the initial and extended Series C rounds for SigTuple. The firm is known for investing in early-stage startups across various sectors.
- Investment Focus Areas: Healthcare, technology, consumer services
- Notable Investments: Not publicly disclosed
- Accel
- Details: Accel is a global venture capital firm that co-led the previous Series C round for SigTuple. The firm invests in early-stage and growth-stage companies across various sectors.
- Investment Focus Areas: Technology, healthcare, consumer services
- Notable Investments: Not publicly disclosed
- Trifecta Capital Advisors
- Details: Trifecta Capital Advisors is a venture capital firm that led the Series C round for SigTuple in April 2019. The firm focuses on providing growth capital to startups.
- Investment Focus Areas: Growth-stage companies, technology, healthcare
- Notable Investments: Not publicly disclosed
- iLabs Capital
- Details: iLabs Capital is a venture capital firm that led the venture round for SigTuple in January 2019. The firm focuses on investing in innovative startups.
- Investment Focus Areas: Startups, technology, healthcare
- Notable Investments: Not publicly disclosed
What's Next for SigTuple?
SigTuple stands on the brink of significant growth, with opportunities for geographical expansion into Europe and the Americas. The company’s flagship product, AI100, has already gained traction in India and other regions, and the upcoming launch of new products promises to broaden their market reach. The recent $4 million funding round will support these initiatives, indicating strong investor confidence.
Future fundraising opportunities seem likely as SigTuple continues to develop its product portfolio and expand into new markets. The company’s focus on AI-driven diagnostics aligns well with industry trends, suggesting that additional funding rounds could be anticipated to support these ambitious plans.
However, challenges remain. Navigating regulatory requirements in different regions and competing with established players in the AI-assisted diagnostics space will be crucial. Ensuring the scalability and reliability of their technology will also be essential as they expand globally. Despite these hurdles, SigTuple’s strategic vision and robust financial backing position them well for future success.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like SigTuple and gather other critical business insights. Sign up for free and unlock the potential of data-driven decision-making today.
